Evonik Corporation

Piscataway, NJ ManufacturingNAICS 325100

Self-funded health planPlan year 2025Renews January
4,512Participants-6% vs. prior year
$10.7MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#18 of 76Manufacturing in NJBy participants

Overview

Evonik Corporation sponsors a self-funded health plan that covered 4,512 participants in plan year 2025, down 6% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, prepaid legal, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
4,512 · prior year 4,780
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Evonik Corporation Consolidated Welfare Benefits Program, plan 501 (4,512 participants); Evonik Corporation Consolidated Retiree Welfare Benefits Program, plan 502 (577 participants)
Stop-loss carrier
Symetra Life Insurance Company; Symetra Life Insurance Company; Symetra Life Insurance Company
Broker compensation
$764K across insured contracts
MedicalLife insuranceDentalVisionPrepaid legalLong-term disabilitySeveranceDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Symetra Life Insurance CompanyStop-loss2,884$7.1M$508K
Hartford Life and AccidentLife, Long-term disability7,322$6.7M$111K
Independent Health AssociationMedical, Prescription drug, HMO49$1.2M—
Aetna Life Insurance CompanyMedical, Prescription drug, PPO, Dental2,029$937K$92K
Capital District Physician's Health Plan Inc.Medical, Prescription drug, HMO34$491K$20K
MetLife Legal PlansLegal825$159K$19K
Magellan Behavioral HealthEmployee Assistance Program4,449$116K—
Hartford Fire Insurance CompanyBusiness Travel Accident4,428$63K$11K
Delta Dental of PennsylvaniaDental47$61K$4K
Teladoc Health, Inc.Expert Medical Opinion4,965$5K—

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$10.7M/ year

Estimated prescription spend: 4,512 participants × $2,371 national average per member. Usually higher once dependents are counted.

$278K–$686K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$81K–$203K
Lower-cost therapeutic alternatives$119K–$248K
Generic pricing vs. actual cost$51K–$154K
PBM contract terms$27K–$80K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Evonik Corporation
Sponsor EIN
63-0673043
Plan numbers
501, 502
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 63-0673043 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Evonik Corporation 401(k) Savings Plan
Type
401(k) plan
Participants
6,589

About this data

Source: Evonik Corporation's Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Evonik Corporation.

Request a correction · Methodology